PortfoliosLab logo

AcelRx Pharmaceuticals, Inc. (ACRX)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$0.26
  • Year Range$0.18 - $1.67
  • EMA (50)$0.28
  • EMA (200)$0.63
  • Average Volume$1.24M
  • Market Capitalization$42.55M

ACRXShare Price Chart


Chart placeholderClick Calculate to get results

ACRXPerformance

The chart shows the growth of $10,000 invested in AcelRx Pharmaceuticals, Inc. on Feb 14, 2011 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $571 for a total return of roughly -94.29%. All prices are adjusted for splits and dividends.


ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACRXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-3.70%-12.57%
YTD-53.57%-18.14%
6M-61.76%-17.07%
1Y-78.51%-5.21%
5Y-37.17%10.07%
10Y-22.84%11.37%

ACRXMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ACRXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current AcelRx Pharmaceuticals, Inc. Sharpe ratio is -0.93. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACRXDividend History


AcelRx Pharmaceuticals, Inc. doesn't pay dividends

ACRXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACRXWorst Drawdowns

The table below shows the maximum drawdowns of the AcelRx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AcelRx Pharmaceuticals, Inc. is 98.63%, recorded on May 12, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.63%Jul 23, 20132218May 12, 2022
-60%Jun 1, 2011135Dec 30, 2011218Nov 26, 2012353
-33.63%Feb 14, 201146Apr 19, 201127May 27, 201173
-33.4%Nov 27, 20128Dec 6, 201229Jan 18, 201337
-21.97%Feb 14, 201323Mar 19, 201316Apr 11, 201339
-15.9%Jun 12, 201310Jun 25, 20135Jul 2, 201315
-10.99%May 17, 20133May 21, 20131May 22, 20134
-9.84%Jan 23, 201312Feb 7, 20134Feb 13, 201316
-9.76%Apr 24, 20136May 1, 20134May 7, 201310
-9.29%Apr 15, 20133Apr 17, 20134Apr 23, 20137

ACRXVolatility Chart

Current AcelRx Pharmaceuticals, Inc. volatility is 177.85%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Portfolios with AcelRx Pharmaceuticals, Inc.


Loading data...

More Tools for AcelRx Pharmaceuticals, Inc.